IL9 and pituitary gland adenoma: Several IL-9 variants (rs31563, rs1859430, rs11741137, and rs2069885) have already been published and identified as potential biomarkers for atopic dermatitis, asthma and its severity, respiratory syncytial virus (RSV) infection, and pituitary adenoma [30–35].